HomeStock MarketPepsiCo, Rivian, and Honeywell gain premarket, while Jupiter and Corning decline.

PepsiCo, Rivian, and Honeywell gain premarket, while Jupiter and Corning decline.

U.S. Stocks Rise as Fed Officials Express Dovish Sentiment

PepsiCo, Unity Software, and Rivian Surge in Premarket Trading

U.S. stocks experienced a boost on Tuesday, driven by dovish comments from Federal Reserve officials. Several of their colleagues are expected to provide further insight later in the session.

Here are the key premarket movers in the U.S. stock market today:

- Advertisement -
  • PepsiCo saw its stock rise by 0.8%. The beverage giant raised its annual profit forecast for the third time this year, benefiting from higher pricing that offset a decline in volumes.
  • Unity Software witnessed a 5.6% increase in its stock price. The video game software maker announced that its CEO, John Riccitiello, would retire following a controversial pricing change that frustrated numerous developers.
  • Rivian experienced a 3% surge in its stock price after UBS upgraded its rating on the electric vehicle manufacturer from ‘neutral’ to ‘buy’. This upgrade reflects a potential buying opportunity following a recent market downturn.

Corning and Juniper Networks Face Stock Declines

However, not all stocks fared well in the premarket trading:

  • Corning encountered a 2.4% decline in its stock price. JPMorgan downgraded the technology company from ‘overweight’ to ‘neutral’, citing significant downside risk to current consensus earnings estimates.
  • Juniper Networks saw its stock fall by 3.5%. JPMorgan also downgraded this networking hardware manufacturer from ‘overweight’ to ‘neutral’, considering it to be the most challenged among its peers in the networking industry.

Honeywell Announces Business Restructuring, Lexicon Pharmaceuticals Receives Preferred Status

On a positive note, Honeywell revealed plans to restructure its business operations into three segments, a move aimed at boosting sales growth and reallocating capital. This announcement led to a 1.2% increase in its stock price.

Lexicon Pharmaceuticals experienced a substantial surge of 9% after its heart failure drug received preferred status at Express Scripts, the pharmacy benefits management unit of Cigna.

- Advertisement -

By offering a comprehensive overview of the premarket U.S. stock market movements, this article provides valuable insights into the current state of the market. It is essential for investors to stay informed about the latest developments in order to make well-informed decisions.

Must Read